Dr. Elizabeth V. Seiverling, MD

Dr. Seiverling practices at Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine.

Dr. Seiverling's NPI, 1952438384, was assigned on February 27, 2007. Dr. Seiverling graduated from Pennsylvania State University College of Medicine in 2006. Dr. Seiverling holds Pennsylvania license MD448202.

Dr. Seiverling's primary practice is Tufts Medical Center, at 800 Washington Street, Boston, MA 02111 in Suffolk County. The practice phone is (617) 636-5000.

Dr. Seiverling's primary practice is Tufts Medical Center in Boston, Massachusetts, part of Tufts Medicine. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Seiverling to 5 more medical groups, 1 group practice or clinic and 1 imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Seiverling practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Seiverling's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Seiverling's licenses on file in 2 states: Pennsylvania and Maine.

CMS data shows 224 Medicare services from Dr. Seiverling across 5 procedure codes in 2024, for 103 Medicare patients. Medicare paid $11,635 for them. Every service was in an office.

CMS counts 103 Medicare patients who saw Dr. Seiverling in 2024. The largest group is 65 to 74, with 41 patients. 72% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Seiverling's median patient age at 57, with 57% women.

In 2024, Dr. Seiverling wrote 117 Medicare Part D claims for 53 patients. 92% of them were for generic drugs. CMS names the drug for 70 of them, across 4 drugs with 11 or more claims each, at $2,133 in total drug cost. In 2022, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Seiverling for performance year 2024, reported as part of a group. Dr. Seiverling accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of removal of skin lesions by Dr. Seiverling, more than 64% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 47 papers to Dr. Seiverling, published from 2014 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Skin Neoplasms, Dermoscopy and Melanoma. Dr. Seiverling has published most often in Dermatol Pract Concept. Dr. Seiverling's most frequent co-authors are Hadjh Tobias Ahrns, MD, Peggy R. Cyr, MD and Ashfaq A. Marghoob, MD.

Dmand AI links Dr. Seiverling to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous.

Dr. Seiverling graduated from Pennsylvania State University College of Medicine in 2006.